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Estimation of podocyte number: A comparison of methods.
Background. The podocyte is the focus of much research into
the mechanisms of renal disease progression, and the number
of podocytes per glomerulus has thus become a parameter of
much interest. When counting podocytes, the actual particle
counted is the cell nucleus. The majority of published studies
estimating podocyte number have used the method of Weibel
and Gomez (1962). This makes assumptions about the shape
and size of the cell nuclei and therefore has an inherent bias. In
our studies we have used a more recent stereologic method—
the disector/fractionator—that makes no assumptions about the
shape or size of the cell nuclei and is therefore free of bias.
Methods. We set out to compare the two methods, in both type
1 diabetic patients and normal controls, to determine whether
eliminating bias and thus improving accuracy had any effect on
the overall results. The Weibel-Gomez method estimates cell
number from a single section through the glomerulus, whereas
the disector/fractionator requires the glomerulus to be serially
sectioned.
Results. There was no significant difference between mean
values obtained by the two methods, providing that the Weibel-
Gomez estimate was performed on electron micrographs. How-
ever, the overall variance was high for all groups of patients,
independent of the method employed.
Conclusion. Although the disector/fractionator is the theo-
retic gold standard method for podocyte number estimation,
comparable estimates can be obtained by the Weibel-Gomez
method provided they are made from electron micrographs.
Thus the technical resources available may determine the choice
of method employed. Investigators should be aware of the high
degree of variability in the estimate, particularly when trying to
detect small changes in podocyte number.
Recently, the podocyte has become the focus of
much research into the mechanisms of progressive
nephropathies. It has been proposed that damage to this
cell is instrumental in the progression of such kidney dis-
eases as focal segmental glomerulosclerosis (FSGS) [1],
diabetic nephropathy [2, 3], and IgA nephropathy [4].
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A proposed hypothesis is that podocyte loss results
in initial widening of remnant foot processes and de-
nuded areas of glomerular basement membrane (GBM).
Both of these adaptations would lead to leakiness of the
filtration barrier and increased proteinuria. Early sup-
portive evidence for this hypothesis came from ultra-
structural examination of the glomerular tuft revealing
foot process widening, denuded GBM and tuft adhesion
in various pathologic conditions [5]. Further evidence
came from studies that examined urine sediments using
immunocytochemistry [6]. These detected substances re-
lated to podocytes—podocalyxin, a3-integrin, and C3b
receptor—in the sediment of patients with a range of
glomerular diseases. The same group has also quantified
the number of urinary podocytes found in samples from
patients with FSGS using the anti-podocalyxin antibody
[7]. They found an average of 0.2 podocytes/mL in dis-
eased patients, with one patient excreting 40 podocytes/
mL.
In recent years, there have been several papers that
have estimated the average number of podocytes in
glomeruli from biopsy material [2–4, 8–10]. However,
these studies have used different methodologies and the
resulting numbers have not been consistent. As this is an
area of increasing interest, we believe that it is impor-
tant that there is a broad understanding of the relative
strengths and weaknesses of the various methods that
have been used.
METHODS
Estimation of number
Number density. The method of number estimation
most used requires estimation of the numerical density
(NV) of the particles of interest and then multiplication
of this by the reference volume (V) in order to derive an
absolute quantity. This is often written as:
N = NV × V (equation 1)
However, there is a potential bias in this method. When
counting particles it is necessary to give each of them
an equal chance of being sampled. Particles in three-
dimensional space that are cut by a two-dimensional sec-
tion will be seen as profiles. Each section will hit a particle
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Fig. 1. Illustration demonstrating the sectioning of glomeruli for the
estimation of podocyte number using (A) Weibel-Gomez and (B)
fractionator method. Abbreviations are: N, total number of cells per
glomerulus; NV, number density; MGV, mean glomerular volume; f,
inverse of sampling fraction; n, number of cells per profile.
in proportion to its size and, more specifically its height
normal to the section. This will therefore bias against
smaller particles in a population.
The method of Weibel and Gomez [11, 12] has at-
tempted to overcome some of these problems using the
equation:
NV = K/b√ N3A/Vv (equation 2)
where NA is the profile density of the particles, Vv is the
volume fraction of the particles, K is a size distribution
coefficient, and b is a shape constant. For most biologic
applications the size distribution coefficient, K, varies be-
tween 1 and 1.05 and can therefore be neglected [12].
Measurements are performed on a single section
through the glomerulus (Fig. 1A). A grid of coarse and
fine points (ratio 1:X) is superimposed onto the glomeru-
lar profile. The numbers of podocyte nuclear profiles (N)
(assuming one nucleus per cell) and coarse points (Ptuft)
hitting the glomerular tuft are counted in order to esti-
mate podocyte nuclear profile density (NA):
NA = n/[Ptuft × area per point] (equation 3)
The number of fine points (Pcell) hitting podocyte nu-
clear profiles are counted to calculate the volume fraction
of podocyte nuclei in glomerular tuft (VV):
VV = Pcell/(Ptuft × X) (equation 4)
where X is the ratio of coarse to fine points.
The number density of cells can then be calculated
from equation 2, with a shape constant chosen depending
upon whether the cells are considered to be spherical, an
ellipse, or an ellipsoid. The shape constant used in this
analysis was for an ellipsoid, 1.55.
This method therefore makes a priori assumptions
about shape and therefore cannot be regarded as be-
Table 1. Comparison of average podocyte number per glomerulus
estimated in control patients from different studies
Podocyte
Number number CV CE
Pagtalunan et al [2] 8 575 ± 127 0.22 0.08
Steffes et al [8] 24 878 ± 220 0.25 0.05
Lemley et al [4] 14 300 ± 107a 0.36 0.10
White et al [9] 10 580 ± 129 0.22 0.07
Dalla Vestra et al [10] 20 833 ± 184 0.22 0.05
CV, coefficient of variation; CE, coefficient of error.
Data are mean ± SD.
aParaffin-embedded tissue.
ing truly unbiased. Podocyte nuclei have a very complex
shape that may change with disease, which the Weibel-
Gomez method cannot accommodate.
In addition, once the estimation of NV is obtained,
there is still a potential bias depending upon the method
chosen for estimation of glomerular volume. Several
methods have been used, with varying levels of precision.
Lane, Steffes, and Mauer [13] compared four methods
for estimating glomerular volume—Cavalieri [14], maxi-
mal profile area (MPA), Weibel and Gomez [11, 12], and
the disector principle [15]. The MPA and Weibel-Gomez
methods assume the glomerulus is either a sphere [13]
or an ellipsoid [16]. Therefore, although they attempt to
correct for this assumption, a further bias is introduced.
The Cavalieri method is considered to be the gold stan-
dard method for estimating volume, as it makes no as-
sumptions about the size or shape of the glomerulus. The
disector method is also free of bias but is generally more
useful for the estimation of number rather than volume.
Any bias introduced by the method chosen for esti-
mation of number density and volume may be amplified
depending upon the tissue processing method. For exam-
ple, embedding in paraffin results in greater overall tis-
sue shrinkage than resin. Thus, if estimates of glomerular
volume are obtained from paraffin-embedded tissue but
podocyte number density is estimated in resin-embedded
tissue, it follows that when multiplying number density
by glomerular volume a smaller absolute number will
result than if both measurements are obtained from resin-
embedded tissue. Although this may not affect the re-
sults of an individual study where like is compared with
like, it makes comparisons between studies more diffi-
cult. This is demonstrated in Table 1, where published
data from control subjects show a wide variation. The av-
erage number of podocytes per glomerulus ranges from
300 ± 107 [4] to 878 ± 220 [8]. The tissue used for glomeru-
lar volume estimation in the study of IgA nephropathy
[4] was paraffin-embedded (podocyte number = 300 ±
107), while the other studies used resin-embedded tissue
(podocyte number = 575 ± 127 to 878 ± 220).
Disector/fractionator. An alternative unbiased
method for the estimation of number is the disector/
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Fig. 2. Illustration demonstrating the sec-
tioning of glomeruli for the estimation of
podocyte number using the disector/fraction-
ator combination. Abbreviations are: N, total
number of cells per glomerulus; Q−, number
of cells counted; f, inverse of sampling frac-
tion = 10 × 6; n, number of cells per profile; t,
distance between profile pairs = 2 lm. Q− is
divided by 2 as the disector is counted in both
directions.
fractionator combination [9, 17], which is independent of
both the size and shape of the particle and its reference
volume.
The basic principle of the fractionator is quite sim-
ple. If the number of particles in a known fraction of
the whole object is counted, multiplying that number by
the sampling fraction will give an unbiased estimate of
the total number (Fig. 1B). For example, in the case of
podocyte number, 1 lm serial sections are taken through
the glomerulus and every tenth section collected, result-
ing in approximately 20 profiles per glomerulus. Then,
starting at a random point, every sixth profile is selected,
resulting in three to four profiles per glomerulus with a
distance between levels of 60 lm. Podocyte nuclear pro-
file number is counted on these profiles and then multi-
plied by the inverse of the sampling fractions to give an
estimate of the total number of cells per glomerulus (i.e.,
total number = number counted × 10 × 6).
Podocyte nuclei are counted using the disector princi-
ple [15]. The only variable that needs to be known is the
distance between adjacent disector pairs (Fig. 2).
A protocol for the estimation of podocyte cell number
per glomerulus is as follows. Starting at a random section-
ing level within the glomerulus, two adjacent glomerular
profiles in serial sections are selected at a set interval, or
fraction, through the glomerulus and each pair viewed
side by side on a computer screen. Those podocyte nuclei
appearing in one profile (the reference section) but not
the other (look-up section) are counted. The efficiency of
the disector can be doubled by then swapping the roles
played by the reference and look-up sections. It is im-
possible for a nucleus counted in one direction to also be
counted in the opposite direction.
The number of cells can then be estimated:
N = (f1 × f2 × . . . . fk)/t × Q−/2 (equation 5)
where fk is the sampling period (reciprocal of the sam-
pling fraction) at the lowest sampling stage, t is the
distance between adjacent profiles, and Q− is the total
number of cell nuclei counted (divided by 2 as the disec-
tor is counted in both directions).
The distance between the adjacent profiles must be
smaller than the diameter of the nuclei measured, but not
so small that there is no discernable difference between
the two sections. The distance selected in our laboratory is
2 lm. For maximum efficiency, the average Q− per biopsy
should be approximately 100.
The accuracy of a microtome for cutting 1 lm sec-
tions can be assessed by cutting a 10 lm “terrace” in the
side of a resin block in 1 lm steps, then measuring the
distance between the block face and terrace by cutting
90 nm gold ultrathin sections. It should take approxi-
mately 111 ultrathin sections to reach the terrace.
We directly compared the Weibel-Gomez and disec-
tor/fractionator methods by estimating podocyte num-
ber in 16 type 1 diabetic patients at baseline and after
3 years, and 10 normal controls. Measurements were car-
ried out on five glomeruli per biopsy. Estimations were
performed in the same glomeruli for each method. For
light microscopy the magnification used was ×1370 and
for electron microscopy ×2000. For the Weibel-Gomez
method, glomerular volume was estimated using the
Cavalieri principle. All tissue was fixed in glutaraldehyde,
post-fixed in osmium tetraoxide, and embedded in epoxy
resin.
The disector/fractionator method was performed using
light microscopy and the Weibel-Gomez method on both
light and electron microscopy. The disector/fractionator
technique was also performed using electron microscopy
on a few glomeruli. However, it proved very difficult to
ensure that the distance between adjacent profile pairs
was 2 lm and therefore this method was not considered
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Table 2. Podocyte number per glomerulus estimated using both the disector/fractionator and Weibel-Gomez methods in 16 type 1 diabetic
patients and 10 control subjects
Disector/fractionator Weibel-Gomez Weibel-Gomez
(light) (light) (electron)
n Mean (95% CI) CV Mean (95% CI) CV Mean (95% CI) CV
Type 1 patients baseline 16 544 (469–619) 0.26 339 (290–389) 0.27 524 (456–592) 0.24
Type 1 patients follow-up 16 475a (422–527) 0.21 355 (301–410) 0.29 467a (388–547) 0.32
Controls 10 580 (487–672) 0.22 383 (341–424) 0.15 616 (507–726) 0.25
CV, coefficient of variation.
aP < 0.05 versus corresponding control.
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Fig. 3. Bland-Altman plot of difference against mean for podocyte
number in 16 type 1 diabetic patients at baseline measured by disec-
tor/fractionator and Weibel-Gomez (electron microscopy).
to be a practical option for the estimation of cell number
and was not included in further analysis.
RESULTS
It can be seen from the results that the disector/
fractionator and Weibel-Gomez methods give similar val-
ues for podocyte number providing that the measure-
ments for Weibel-Gomez are carried out using electron
microscopy (Table 2). The values obtained using the
Weibel-Gomez method on light microscopy sections are
significantly lower (P < 0.001).
There are no significant differences between control
subjects and diabetic patients at baseline using any of the
three methods. At follow-up, however, both the disec-
tor/fractionator and Weibel-Gomez electron microscopy
method show a significant reduction in podocyte number
in diabetic patients compared to controls (P = 0.028, P =
0.022, respectively). There is no significant difference de-
tected using the Weibel-Gomez light microscopy method
(P = 0.45).
A Bland and Altman [18] plot shows that despite there
being no statistically significant differences in podocyte
number estimated by the Weibel-Gomez electron mi-
croscopy or disector/fractionator methods, there is, how-
ever, a lack of agreement of the estimate obtained by the
two methods (Fig. 3). The mean difference in the type 1
patients at baseline is 20, with 95% CI of −43 to 83.
In control patients there is no significant difference in
the within-patient variability obtained by Weibel-Gomez
electron microscopy or disector/fractionator. In the type 1
patients at baseline, however, the within-patient variabil-
ity is significantly lower using the disector/fractionator
(P = 0.008). This difference is not evident as disease pro-
gresses (P = 0.113).
DISCUSSION
Despite the inherent bias in the Weibel-Gomez method
due to assumptions about the shape and size of podocyte
nuclei, it would appear that a reasonable estimate
of podocyte number may be obtained comparable to
that observed with the unbiased disector/fractionator
method—providing that electron micrographs are used
for the Weibel estimation. The main drawback of the dis-
ector/fractionator is that it is much more time-consuming
than the Weibel-Gomez method as it requires exhaustive
serial sectioning of the glomerulus. It takes a minimum
of 3 days to serially section and count five glomeruli per
biopsy. However, although a single section through each
glomerulus may take less time for the Weibel-Gomez
method, obtaining electron micrographs of glomerular
profiles is more expensive and obviously requires access
to an electron microscope, something that is not available
to all researchers. In addition, the Weibel-Gomez method
may also require serial sectioning depending upon the
method chosen for estimation of glomerular volume. In
this case, the Weibel-Gomez method becomes less cost ef-
fective than the disector/fractionator. However, it should
be noted that if electron microscopy is being used to es-
timate other glomerular parameters, the additional cost
of estimating podocyte number is negligible.
The estimation of podocyte number using Weibel-
Gomez and light microscopy appears to be further bi-
ased, although the reasons for this are not obvious. As
the Weibel-Gomez method is performed on a single level
through the glomerulus, the number of nuclear profiles
counted can be quite low. Therefore, just a few missed
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nuclei at the light compared to electron microscopy level
may result in a proportionally greater difference in over-
all podocyte number. It may be possible to reduce this dis-
crepancy by performing counts on multiple levels through
the glomerulus; this, however, will also decrease the cost
effectiveness of this method.
Although there is some evidence from looking at
within-patient variability that the disector/fractionator
method improves precision in diabetes, the overall high
variance of the estimate may mean that these small in-
creases in precision are of little practical consequence.
The high variability of the estimate also suggests that
small changes in podocyte number will be difficult to de-
tect. Our recently published data show no significant dif-
ference in podocyte number in 50 type 1 diabetic patients
at baseline compared to 10 controls, whereas there was
in fact a 10% difference in absolute podocyte number
[9]. After 3 years of follow-up a significant difference was
detected, with an 18% reduction in absolute podocyte
number.
CONCLUSION
The Weibel-Gomez method requires assumptions to be
made regarding the shape and size of podocyte cell nuclei
and therefore could be dismissed on the basis that they
introduce unquantifiable bias in the estimate. However,
in practical terms the actual estimates of podocyte num-
ber using the two methods are not statistically different;
therefore, the method chosen by researchers may depend
upon the available resources. The disector/fractionator
offers the theoretic advantage of lack of bias and could
therefore be considered as a gold standard. In addition,
depending upon the method chosen for estimation of
glomerular volume, it may be more cost effective. Inves-
tigators should be aware of the high variability of the
estimate when planning studies looking at podocyte loss
in pathologic disease processes.
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